Topiramate
Product Images NDC 68071-4756

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68071-4756). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4756 6

This is a medication warning label for Topiramate 50mg tablets. It cautions to keep out of reach of children and provides details such as the lot number, expiration date, dosage, and manufacturer's NDC. It also advises that the medication should be taken only as directed by a doctor and that side effects should be immediately reported to a doctor or the FDA. The medication should be stored at a controlled temperature between 68-77°F.*

FDA Label Image

Structured Product Formula For Topiramate (Af70d392 31a6 40bb 8f0a Ab51a70067fb 01)

FDA Label Image

Structured Product Formula For Topiramate (Af70d392 31a6 40bb 8f0a Ab51a70067fb 02)

FDA Label Image

Topiramate Tablets Usp (Af70d392 31a6 40bb 8f0a Ab51a70067fb 03)

This is a table showing the results of a study on the change in average monthly migraine period rate from baseline to double-blind phase. The study involved a placebo group and three different dosages of topiramate (50mg/day, 100mg/day, and 200mg/day). There are two different participant group sizes listed for each dosage of topiramate. The table includes asterisks indicating statistical significance for the results with p-values of less than 0.001 and less than 0.01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.